even though kennedy disease sbma related gene replacement therapy mentioned two articles shows another major step forward type treatment accomplish type results sma potential treatment spinal bulbar muscular atrophy little closer gene therapy animation short nicely explained youtube video note information parents children sma want learn study participation visit studysmanow well written article explaining dr mendell research nationwide children good job explaining treatment process phase replacement therapy article sma progressive childhood neuromuscular disease caused mutation single gene children sma fail meet motor milestones typically die require permanent mechanical ventilation years age phase clinical trial first test functional replacement mutated gene responsible sma one time intravenous injection modified adeno associated virus serotype aav delivered smn gene patients three patients received low dose patients received high dose phase trial patients high dose group demonstrated improvement motor function decreased need supportive care compared natural history disease specifically end study period patients appeared favorable safety profile generally well tolerated patients treated high dose percent patients achieved head control percent patients roll percent patients sit assistance seventy five percent patients sitting seconds longer two patients crawl pull stand stand walk independently according natural history disease patients require nutritional respiratory support months age able swallow speak effectively patients received high dose study patients able speak patients fed orally seven require bi level positive airway pressure data cut august